347 related articles for article (PubMed ID: 23773347)
21. ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France].
Abadie D; Durrieu G; Roussin A; Montastruc JL;
Therapie; 2013; 68(2):77-84. PubMed ID: 23773348
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
[TBL] [Abstract][Full Text] [Related]
24. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
25. Veterinary pharmacovigilance. Part 5. Causality and expectedness.
Woodward KN
J Vet Pharmacol Ther; 2005 Apr; 28(2):203-11. PubMed ID: 15842308
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacovigilance as new direction of research].
Gaszner G; Makkos Z; Gaszner P
Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
[TBL] [Abstract][Full Text] [Related]
27. [Safety of medicinal products and reporting of adverse drug reactions].
Skibicka I; Maciejczyk A
Neurol Neurochir Pol; 2004; 38(6):503-10. PubMed ID: 15654675
[TBL] [Abstract][Full Text] [Related]
28. [Informativity of French web forums for the evaluation of side effects of baclofen].
Karapetiantz P; Lillo-Le Louët A; Bousquet C
Therapie; 2019 Dec; 74(6):569-578. PubMed ID: 31253414
[TBL] [Abstract][Full Text] [Related]
29. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
30. Measuring the preventability of adverse drug reactions in France: A 2015 overview.
Olivier-Abbal P
Therapie; 2016 Apr; 71(2):195-202. PubMed ID: 27080838
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacovigilance in practice].
Spreux A; Baldin B; Chichmanian RM
Transfus Clin Biol; 1999 Jul; 6(4):254-9. PubMed ID: 10472690
[TBL] [Abstract][Full Text] [Related]
32. Principles of signal detection in pharmacovigilance.
Meyboom RH; Egberts AC; Edwards IR; Hekster YA; de Koning FH; Gribnau FW
Drug Saf; 1997 Jun; 16(6):355-65. PubMed ID: 9241490
[TBL] [Abstract][Full Text] [Related]
33. [Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future].
Tissier MH; Lepagnol F
Therapie; 2002; 57(3):273-82. PubMed ID: 12422542
[TBL] [Abstract][Full Text] [Related]
34. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
[TBL] [Abstract][Full Text] [Related]
35. [Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].
Benedetti-Bardet C; Guy C; Boudignat O; Regnier-Zerbib A; Ollagnier M;
Therapie; 2001; 56(3):295-9. PubMed ID: 11475811
[TBL] [Abstract][Full Text] [Related]
36. Veterinary pharmacovigilance in the European context.
Keck G
Ann Ist Super Sanita; 1992; 28(4):425-8. PubMed ID: 1303032
[TBL] [Abstract][Full Text] [Related]
37. [Terappel: description of a computerised database and examples of studies].
Vial T; Gouraud A; Bernard N
Therapie; 2014; 69(1):31-8. PubMed ID: 24698186
[TBL] [Abstract][Full Text] [Related]
38. Electronic Reporting for Clinical Drug Safety and Pharmacovigilance. 29 - 30 October 2002, Amsterdam, The Netherlands.
Hennig R
Expert Opin Drug Saf; 2003 Mar; 2(2):195-7. PubMed ID: 12904118
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
40. Report of Adverse Events in Colombia: A Successful Case.
Moreno-Mattar O; Ramírez R; Alvarado A; Sierra F; Guzmán J
Curr Drug Saf; 2019; 14(1):53-56. PubMed ID: 30411692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
